XML 37 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Awards (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Valuation Assumptions of Stock Options Granted

The assumptions that the Company used to determine the grant-date fair value of the stock options granted to employees and directors during the six months ended June 30, 2022 and 2021 were as follows, presented on a weighted average basis:

 

 

 

Six Months Ended
June 30, 2022

 

 

Six Months Ended
June 30, 2021

 

Risk-free interest rate

 

2.46%

 

 

0.96%

 

Expected term (in years)

 

 

5.9

 

 

 

6.2

 

Expected volatility

 

94.2%

 

 

91.0%

 

Expected dividend yield

 

0%

 

 

0%

 

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity since January 1, 2022:

 

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Term in Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2021

 

 

9,375,497

 

 

$

1.79

 

 

 

8.5

 

 

$

4

 

Granted

 

 

3,148,500

 

 

 

0.46

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

0.00

 

 

 

 

 

 

 

Canceled, forfeited or expired

 

 

(1,401,565

)

 

 

1.02

 

 

 

 

 

 

 

Outstanding at June 30, 2022

 

 

11,122,432

 

 

$

1.51

 

 

 

8.2

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable at June 30, 2022

 

 

5,099,852

 

 

$

2.21

 

 

 

7.0

 

 

$

 

Options vested and expected to vest at June 30, 2022

 

 

10,902,956

 

 

$

2.21

 

 

 

8.1

 

 

$

 

Summary of Restricted Stock Unit Activity

The following table summarizes the Company’s restricted stock activity since January 1, 2022:

 

 

 

 

 

 

Weighted-Average

 

 

 

Number of

 

 

Grant Date Fair Value

 

 

 

Units

 

 

per Unit

 

Outstanding, non-vested at December 31, 2021

 

 

 

 

$

 

Issued

 

 

250,000

 

 

 

0.39

 

Vested

 

 

(250,000

)

 

 

0.39

 

Canceled/forfeited

 

 

 

 

 

 

Outstanding, non-vested at June 30, 2022

 

 

 

 

 

 

Summary of Stock Based Compensation Expense

The Company recorded stock-based compensation expense related to stock options and restricted stock units in the following expense categories of its statements of operations and comprehensive loss:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

Research and development expenses

$

178

 

 

$

103

 

 

$

321

 

 

$

202

 

 

General and administrative expenses

 

350

 

 

 

258

 

 

 

896

 

 

 

791

 

 

Total Stock Based Compensation

$

528

 

 

$

361

 

 

$

1,217

 

 

$

993